Nanomedicine: A modern advent for combating COVID-19
DOI:
https://doi.org/10.47391/JPMA.5370Abstract
Madam,
Our current understanding of the COVID-19 virus and its vulnerabilities has not been translated into the approval of its standard line of treatment. COVID-19, although primarily a respiratory ailment, may culminate in acute respiratory distress syndrome, hyperinflammatory response, sepsis, and multiorgan failure, which often carry a grave prognosis. Drugs addressing such severities of COVID-19 are often limited by their therapeutic indices, bioavailability, and side effects, necessitating the exploration of new avenues to counter them. The ever-evolving field of nanotechnology presents one such example.
Downloads
Published
2022-02-12
How to Cite
Muhammad Ahsan Khan, Ahya, & Siddiqui, M. S. . (2022). Nanomedicine: A modern advent for combating COVID-19. Journal of the Pakistan Medical Association, 72(6), 1269–1269. https://doi.org/10.47391/JPMA.5370
Issue
Section
Letter to the Editor